Te Rongoā Koiora i roto i te Rangahau e Pā Ana ki te Mate Huka Momo 2
Ko te mate huka momo 2 (T2DM) tētahi o ngā mate pūmua tawhito e tino kitea ana puta noa i te ao, ā, he wero nui tēnei ki ngā pūnaha hauora. Ko te āhua o tēnei mate ko te pikinga tonu o ngā taumata huka toto nā te whakakotahitanga o te ātete ki te insulin me te ngoikore o te mahi a ngā pūtau beta o te pancreas. I ngā tekau tau tata nei, kua whai wāhi nui ngā huarahi hauora ki te mārama ki ngā tikanga mate, ki te kimi i ngā tohu koiora, ki te whakawhanake i ngā rongoā, me te whakapai ake i ngā rautaki ārai me te aroturuki. Kāore te rangahau hauora e aro noa ki te huka toto engari ki te tirotiro hoki i ngā taunekeneke uaua i waenga i ngā ira, te momo noho, te mumura, te microbiota puku, me ngā āhuatanga taiao e awe ana i te haerenga o te T2DM.
Te Mārama ki te Pathophysiology mā te Huarahi Hauora
Ko tētahi o ngā takoha nui a te rongoā koiora ko te mahere i ngā tukanga koiora e pā ana ki te T2DM. Ka puta te ātete insulin ina kore ngā pūtau o te tinana, inā koa te uaua, te ate, me te kiko ngako, e aro pai ki te insulin. Nō reira, kāore e taea e te huka te uru ki ngā pūtau hei whakamahi pūngao, ka hua ake he kohikohinga ki roto i te toto. E whakaatu ana ngā rangahau koiora he hononga tata te ātete insulin ki te kohikohinga ngako visceral, te ngoikore o te mitochondrial, te ahotea oxidative, me te mumura iti mau tonu.
I tētahi atu taha, ka whakanuia e te repe taiaki te hanga insulin i te tīmatanga hei utu mō te ātete. Heoi, i roto i te wā, ka ngenge ngā pūtau beta repe taiaki, ā, ka heke te whakaputanga insulin. E whakaatu ana ngā rangahau hauora hou i te mahi a te lipototoxicity (te pānga o ngā waikawa ngako kore utu), te glucotoxicity (te roa o te pānga ki te huka toto tiketike), me te apoptosis me te dedifferentiation o ngā pūtau beta. He mea nui tēnei māramatanga nā te mea ka āwhina i ngā kairangahau ki te hoahoa i ngā maimoatanga e aro ana ki te pūtake o te mate, kaua ki te whakaheke noa i te huka toto.
Ngā Ira, Ngā Epigenetics, me te Mōrearea o te Mate Huka Momo 2
Kei te whakaatu tonu ngā rangahau koiora he kaha te wāhanga ira o te T2DM, ahakoa kāore i te tino whakatauhia. Kua tautuhia e ngā rangahau hononga whānui-ira (GWAS) ngā rau o ngā momo ira e pā ana ki te mōrearea o te T2DM, tae atu ki ērā e pā ana ki te mahi pūtau beta, te pākia o te ngako, me te whakahaere i te insulin. Heoi, kāore e ranea te ira anake hei whakamārama i te pikinga o ngā take T2DM, nō reira kua neke te arotahi ki te epigenetics.
Ka rangahau te epigenetics i ngā panonitanga o te whakaaturanga ira me te kore e whakarerekē i te raupapatanga DNA, hei tauira mā te methylation DNA me ngā whakarerekētanga histone. Ka taea e ngā āhuatanga pēnei i te kai nui-kaiora, te kore o te korikori tinana, te ahotea, me te pānga ki ngā poke te awe i ngā kōtaha epigenetic me te whakanui ake i te mōrearea o te T2DM. Inaa, e kī ana ētahi taunakitanga ka taea te puta ngā panoni epigenetic i te wā e hapu ana, ka taea ai te "whakarite" i te mōrearea pākia i te wā wawe. Koinei te take e whai wāhi ai te rongoā koiora ki te whakawhanake i ngā rautaki ārai e ahu mai ana i te huringa ora.
Ngā Tohu Koiora me ngā Tātaritanga: Mai i te Huka ki te Omics
Nā ngā whanaketanga koiora kua taea te whakawhanake i tētahi whānuitanga o ngā tohu koiora i tua atu i te huka nohopuku me te HbA1c. He maha ngā rangahau mō ngā tohu koiora mumura pēnei i te CRP, IL-6, me te TNF-α nā te mea he wāhanga matua o te T2DM te mumura mau tonu. Hei tāpiri, kua arohia ngā adipokines pēnei i te adiponectin me te leptin nā te mea he hononga tata ki te kiko ngako me te aro o te insulin.
Ko te hurihanga "omics" (genomics, proteomics, metabolomics, me lipidomics) kei te akiaki i te kitenga o ngā tohu koiora hou ka taea te matapae i te whanaketanga o te T2DM me ōna raruraru. Hei tauira, kua tautuhia e te Metabolomics ngā tauira waikawa amino mekameka peka (BCAA) me ngā kōtaha lipid motuhake e pā ana ki te ātete insulin. Mā tēnei huarahi, kei te neke haere te rangahau hauora ki te rongoā tika: ngā maimoatanga me te aukati i whakaritea ki ngā āhuatanga koiora o te tangata.
Te Tūranga o ngā Microbiota Puku i roto i te Mate Huka Momo 2
Ko tētahi wāhanga rangahau koiora e tere tipu haere ana ko te whanaungatanga i waenga i ngā moroiti puku me te pākia o te huka. Ka awe ngā moroiti puku i te mimiti matūkai, te hanga waikawa ngako mekameka poto (SCFA), me te pumau o te ārai puku. Ka taea e te kore taurite o ngā moroiti (dysbiosis) te whakanui ake i te urunga o te puku me te whakaoho i te mumura pūnaha mā roto i ngā endotoxins pēnei i te lipopolysaccharide (LPS). Kātahi ka whakanui ake tēnei mumura i te ātete insulin.
Kei te tūhuratia e ngā rangahau koiora te pūmanawa o ngā wawaotanga e ahu mai ana i ngā microbiota, pērā i ngā probiotics, ngā prebiotics, ngā synbiotics, me te whakawhitinga microbiota paru (FMT). Ahakoa he rerekē tonu ngā hua, ā, e hiahiatia ana he whakamātautau haumanu nui ake, he pai te hua o tēnei mara mō ngā huarahi rongoā hou, whānui ake.
Te Whakawhanaketanga Whakaora: Ngā Auahatanga Rongoā me te Hangarau Koiora
I roto i te ao rongoā, kua whakawhanakehia e te rongoā koiora ngā momo rongoā hei whakahaere i te T2DM. Ko te Metformin te rongoā raina tuatahi nā te mea ka whakapai ake i te aro o te insulin me te whakaiti i te hanga huka toto ate. Ko ētahi atu momo rongoā, pērā i te sulfonylureas me te thiazolidinediones, ka mahi i ngā ara rerekē. Heoi, ko tētahi auahatanga nui i roto i ngā tekau tau e rua kua pahure ake nei ko te putanga mai o ngā agonists receptor GLP-1 me ngā aukati SGLT2.
Ehara i te mea ka āwhina noa ngā agonists GLP-1 ki te whakaheke i te huka toto engari ka tautoko hoki i te whakaheke taumaha, ā, he painga hoki ki te ngākau. I taua wā, ka mahi ngā aukati SGLT2 mā te whakanui ake i te whakaputanga huka i roto i te mimi, ā, kua whakaatuhia he whakaiti i te mōrearea o te ngoikore o te ngākau me te whakaroa i te haere whakamua o te mate tākihi mau tonu. Kei te akiakihia hoki e te rangahau koiora te whanaketanga o ngā maimoatanga whakakotahi, te whakamahinga o ngā homoni rite, me ngā rongoā hou e aro ana ki te mumura me te pākia o te ngako.
I roto i te hangarau koiora, ka tukuna e te rangahau pūtau take me te whakahoutanga pūtau beta repeure he tumanako mō te heke mai. Kei te tūhuratia hoki ngā huarahi whakarerekētanga ārai mate, te whakaora ira, me te hangarau kiko hei aro atu ki ngā pūtake o te ngoikore o te repeure, ahakoa kei te raru tonu te tono ki te T2DM.
Ngā Tauira Rangahau: Mai i ngā Pūtau ki ngā Taupori
Ka whakamahia e ngā rangahau koiora ngā tauira maha hei mārama ki te T2DM. Ka whakamahia e ngā rangahau in vitro ngā ahurea pūtau hei tirotiro i te tohu insulin, te ahotea waikura, ngā pānga rongoā rānei. Mā ngā tauira kararehe, pērā i ngā kiore kai momona-nui, ngā kiore whakawhiti-ira rānei, ka āwhina i te mārama ki te ahunga me ngā raruraru o te mate. I taua wā, kei roto i ngā rangahau tangata ngā whakamātautau haumanu, ngā rangahau kohort wā roa, me ngā rangahau taunakitanga o te ao tūturu (RWE) e whakamahi ana i ngā pūkete hauora hiko.
Mā te whakaurunga o ngā raraunga mai i ngā taumata maha ka taea te mārama whānui ake. I tēnei wā, kei te tīmata hoki te whakamahi i te matauranga horihori (AI) ki te tukatuka i ngā raraunga nui mai i ngā omics, ngā whakaahua hauora, me ngā tuhinga haumanu hei matapae i ngā mōrearea, ngā urupare rongoā, me te putanga mai o ngā raruraru.
Ngā raruraru me te ārai: He arotahi koiora kore e taea te wehe
E pā ana te T2DM ki ngā raruraru nui pērā i te mate ngakau, te whiu, te mate huka nephropathy, te neuropathy, me te retinopathy. Ka tirotirohia e ngā huarahi koiora ngā tikanga o te kino o ngā oko toto i puta mai i te hyperglycemia mau tonu, tae atu ki te hanganga o ngā hua mutunga glycation matatau (AGEs), te ngoikore o te endothelial, me te whakahohenga o ngā ara mumura. He mea nui ēnei kitenga ki te whakawhanake i ngā maimoatanga tiaki-okana me ngā rautaki aroturuki wawe.
Hei tāpiritanga, ka tautoko te rongoā koiora i te ārai mā roto i ngā rangahau mō ngā wawaotanga o te momo noho me te kai totika, pērā i te pānga o te kai muka nui, te whakawhāiti karori, te kai Mediterranean rānei ki te aro o te insulin. E whakaatu ana ngā rangahau ka taea e te whakaheke taumaha ngawari me te whakakorikori tinana auau te whakaiti i te mōrearea o te T2DM, inā koa i roto i ngā tāngata whai prediabetes. Nō reira, ehara i te mea ko te rongoā koiora anake te akiaki i te auahatanga rongoā engari ka whakapakari hoki i ngā taunakitanga pūtaiao mō ngā kaupapa here hauora tūmatanui.
Te Katinga
Kua whanake te rangahau koiora e pā ana ki te mate huka momo 2 mai i te ako i te hukahuka ki te tūhuratanga hohonu o ngā whatunga pākia, te ira, te epigenetics, te microbiota, me ngā taunekeneke taiao. E kitea ana ōna takoha ki te mārama ki te pathophysiology, te kitenga o ngā biomarkers, te auahatanga rongoā, me ngā huarahi ārai kua arotahi ake. I te anga whakamua, ko te whakaurunga o te omics, te hangarau matihiko, me te rongoā tika ka taea te whakarato i te whakahaere T2DM whaiaro ake, whai hua, me te pumau. I te pikinga o te taumahatanga o te T2DM puta noa i te ao, he pou nui te rangahau koiora hei whakaiti i ngā raruraru me te whakapai ake i te kounga o te oranga mō te miriona tāngata.
